Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine and Accelerated iTBS for Suicidal Ideation
NCT06121284Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Mar 2024
- Primary completion
- Jul 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of d-cycloserine in suicidal ideation, sponsored by University of Calgary. Primary endpoint: Performance on the Death Implicit Association Test at 2 weeks. Started Mar 2024; status: recruiting.
02
Drugs
d-cycloserine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT06121284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121284.